HealthBioArctic Says Novartis Ends Deal With Up to US$772 Million in Potential MilestonesBy Naomi CalderNov 2, 2026, 10:38 PM UTC
HealthFDA Approves Voceryq for Adults With Recurrent Respiratory PapillomatosisBy Naomi CalderOct 30, 2026, 10:11 PM UTC
BusinessFormation Bio Announces $600 Million Fund for Clinical-Stage Drug ProgramsBy Helena WardOct 28, 2026, 6:29 PM UTC
PoliticsChina Opposes U.S. Plan That Would Add Biotech to Investment ControlsBy Julian ArdentOct 26, 2026, 1:08 AM UTC
PoliticsChina Reserves Right to Respond to U.S. Biotech Investment RulesBy Julian ArdentOct 24, 2026, 3:40 PM UTC
BusinessFour University Students Join YZi Labs’ First Atlas Scout GroupBy Helena WardOct 24, 2026, 10:48 AM UTC
InvestingModerna Shares Fall 17.57%, Leaving Year-to-Date Gain at 587%By Celia RowanOct 22, 2026, 10:45 PM UTC
BusinessCytoDyn Taps Finance Chief Hoffman as CEO Amid Funding PressureBy Helena WardOct 20, 2026, 5:45 AM UTC
